FDA NDC Directory · JSON-LD · Markdown

Viokace

NDC 73562-104 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namePancrelipase
Labeler / ManufacturerAimmune Therapeutics, Inc.
Marketing categoryBiologic License Application · App BLA022542
Dosage form / routeTABLET · ORAL
Active ingredientsPANCRELIPASE AMYLASE (39150 [USP'U]/1)
PANCRELIPASE LIPASE (10440 [USP'U]/1)
PANCRELIPASE PROTEASE (39150 [USP'U]/1)
Marketing started20210301
Package count1

External sources

Source: openFDA. Public-domain (CC0).